User login
- /content/phase-3-data-support-apixaban-cancer-associated-vte
- /familypracticenews/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /hematologynews/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer-associated
- /internalmedicinenews/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /vascularspecialistonline/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /anticoagulationhub/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /jcomjournal/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer-associated-vte
- /hematology-oncology/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /internalmedicine/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer
- /familymedicine/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer-associated
- /chestphysician/article/191108/patient-survivor-care/phase-3-data-support-apixaban-cancer-associated